您的位置: 首页 > 农业专利 > 详情页

면역조절 T 세포를 포함하는 자가면역 질환 세포치료제
专利权人:
CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
发明人:
CHO, MI LA,조미라,PARK, MIN JUNG,박민정,LEE, SUNG HEE,이성희
申请号:
KR1020120032089
公开号:
KR1020130110283A
申请日:
2012.03.29
申请国别(地区):
KR
年份:
2013
代理人:
摘要:
PURPOSE: A composition containing regulatory T cells for treating autoimmune diseases is provided to promote the generation of regulatory B cells and to suppress activation of antibody producing B cells, thereby treating immune diseases including autoimmune diseases.CONSTITUTION: A composition for treating autoimmune diseases contains regulatory T cells. The composition promotes generation of regulatory B cells and suppresses the activation of antibody producing B cells. The regulatory T cells are autologous. The regulatory T cells include natural regulatory T cells and adaptive regulatory T cells. The regulatory T cells are differentiated by anti-CD3 and anti-CD28 antibodies and TGF-beta.COPYRIGHT KIPO 2013본원은 면역조절 T 세포를 포함하는 자가면역 질환 치료용 조성물을 개시한다. 본원의 조성물은 면역조절 B 세포의 생성을 촉진하고, 항체 생산 B 세포의 활성을 억제함으로써, 자가면역질환을 포함하는 면역질환의 치료에 유용하게 사용될 수 있다.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充